Patents by Inventor Roman Ariel Galetto

Roman Ariel Galetto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric antigen receptors targeting CD70
    Patent number: 11396551
    Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: July 26, 2022
    Assignee: Pfizer Inc.
    Inventors: Surabhi Srivatsa Srinivasan, Niranjana Aditi Nagarajan, Siler Panowski, Yoon Park, Tao Sai, Barbra Johnson Sasu, Thomas John Van Blarcom, Mathilde Brunnhilde Dusseaux, Roman Ariel Galetto
  • Chimeric antigen receptors targeting B-cell maturation antigen
    Patent number: 11312782
    Abstract: The invention provides CARs (CARs) that specifically bind to BCMA (B-Cell Maturation Antigen). The invention further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The invention further relates to therapeutic methods for use of these CARs and engineered immune cells for the treatment of a condition associated with malignant cells expressing BCMA (e.g., cancer).
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: April 26, 2022
    Assignee: Pfizer Inc.
    Inventors: Tracy Chia-Chien Kuo, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Philippe Duchateau, Roman Ariel Galetto, Alexandre Juillerat, Thomas Charles Pertel, Arvind Rajpal, Barbra Johnson Sasu, Cesar Adolfo Sommer, Julien Valton, Thomas John Van Blarcom
  • CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN
    Publication number: 20190241669
    Abstract: The invention provides CARs (CARs) that specifically bind to BCMA (B-Cell Maturation Antigen). The invention further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The invention further relates to therapeutic methods for use of these CARs and engineered immune cells for the treatment of a condition associated with malignant cells expressing BCMA (e.g., cancer).
    Type: Application
    Filed: April 15, 2019
    Publication date: August 8, 2019
    Inventors: Tracy Chia-Chien KUO, Bijan Andre BOLDAJIPOUR, Javier Fernando CHAPARRO RIGGERS, Philippe DUCHATEAU, Roman Ariel GALETTO, Alexandre JUILLERAT, Thomas Charles PERTEL, Arvind RAJPAL, Barbra Johnson SASU, Cesar Adolfo SOMMER, Julien VALTON, Thomas John VAN BLARCOM
  • CHIMERIC ANTIGEN RECEPTORS TARGETING CD70
    Publication number: 20190233528
    Abstract: The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).
    Type: Application
    Filed: January 31, 2019
    Publication date: August 1, 2019
    Applicant: Pfizer Inc.
    Inventors: Surabhi Srivatsa Srinivasan, Niranjana Aditi Nagarajan, Siler Panowski, Yoon Park, Tao Sai, Barbra Johnson SASU, Thomas John Van Blarcom, Mathilde Brunnhilde Dusseaux, Roman Ariel Galetto